Overall (n = 95) | eGFR (ml/min/1.73 m2) | P value | |||
---|---|---|---|---|---|
< 30 (n = 25) | 30–59 (n = 61) | ≥60 (n = 9) | |||
Demographic data | |||||
Age, years | 54.31 ± 11.92 | 58.88 ± 9.75 | 55.15 ± 9.20 | 35.89 ± 17.20 | 0.0007* |
Sex, men, n (%) | 81(85.26) | 19(76.00) | 54(88.52) | 8(88.89) | 0.318 |
BMI (kg/m2) | 24.54 ± 3.83 | 23.89 ± 3.15 | 24.70 ± 4.08 | 25.25 ± 3.92 | 0.575 |
History of alcohol | 29(30.53) | 10(40.00) | 17(27.87) | 2(22.22) | 0.464 |
History of smoking | 63(66.32) | 16(64.00) | 41(67.21) | 6(66.67) | 0.960 |
Hypertension | 39(41.05) | 15(60.00) | 21(34.43) | 3(33.33) | 0.083 |
Diabetes mellitus | 34(35.79) | 12(48.00) | 19(31.15) | 3(33.33) | 0.334 |
Chronic kidney disease | 20(21.05) | 12(48.00) | 6(9.84) | 2(22.22) | 0.0005* |
Pretransplant characteristics | |||||
DCM | 38(40.00) | 7(28.00) | 26(42.62) | 5(55.56) | 0.279 |
CAD | 27(28.42) | 9(36.00) | 16(26.23) | 2(22.22) | 0.604 |
Valve disease | 15(15.79) | 3(12.00) | 10(16.39) | 2(22.22) | 0.756 |
Pre-PCI | 11(11.58) | 4(16) | 7(11.48) | 0(0) | 0.441 |
ICD implantation | 3(3.16) | 2(8.00) | 1(1.64) | 0(0) | 0.267 |
LVAD implantation | 1(1.05) | 0(0) | 0(0) | 1(11.11) | 0.008* |
Cardiac tumor | 1(1.05) | 0(0) | 1(1.64) | 0(0) | 0.755 |
EF pre-HTx (%) | 28(23,31) | 30(24,33) | 26(23,30) | 25(20,30) | 0.257 |
Creatinine (mg/dL) | 1.14(0.95,1.27) | 1.60(1.33,1.91) | 1.10(0.95,1.22) | 0.76(0.70,0.87) | <.0001* |
Intraoperative characteristics | |||||
CPB duration (min) | 225(183,262) | 225(180,270) | 220(193,255) | 210(180,225) | 0.822 |
Blood transfusion (ml) | 1440(1100,2100) | 1400(1100,2000) | 1440(1100,2200) | 1640(1000,2050) | 0.849 |
Infusion (ml) | 1810(1320,2440) | 2000(1505,2580) | 1800(1320,2350) | 1700(1190,1925) | 0.483 |
Blood loss (ml) | 1000(1000,2200) | 1500(1000,2500) | 1000(1000,2000) | 1500(1000,2000) | 0.804 |
Urine volume (ml) | 1800(1200,2500) | 1300(770,1650) | 2000(1300,2500) | 2150(2000,2900) | 0.001* |
IABP/ECMO | 6(6.32) | 4(16.00) | 2(3.28) | 0(0) | 0.065 |
Postoperative characteristics | |||||
AKI stage | |||||
NO-AKI | 62(65.26) | 16(64.00) | 40(65.57) | 6(66.67) | 0.428 |
Stage 1 | 9(9.47) | 0(0) | 8(13.11) | 1(11.11) | |
Stage 2 | 8(8.42) | 2(8.00) | 4(6.56) | 2(22.22) | |
Stage 3 | 16(16.84) | 7(28.00) | 9(14.75) | 0(0) | |
Urine volume | |||||
1st Day after operation | 2200(1980,2805) | 2100(1965,2485) | 2200(1980,2735) | 2525(2115,3320) | 0.194 |
2nd Day after operation | 2125(1765,2505) | 1935(1400,2498) | 2135(1845,2500) | 2425(2005,2970) | 0.081 |
3rd Day after operation | 2110(1860,2050) | 2050(1400,2498) | 2145(1930,2450) | 2305(2050,2440) | 0.300 |
Mechanical ventilation (min) | 1080(840,2220) | 1920(960,3720) | 1040(783,2100) | 960(720,1410) | 0.134 |
RRT | 16(16.84) | 7(28.00) | 9(14.75) | 0(0) | 0.123 |
Time from operation to discharge (days) | 26(22,33) | 29(23,37) | 26(22,32) | 24(20,26) | 0.370 |
Death | 15(15.79) | 4(16.00) | 10(16.39) | 1(11.11) | 0.921 |
Mortality in hospital | 11(11.58) | 4(16.00) | 6(9.84) | 1(11.11) | 0.719 |
Death within 1 year | 3(3.16) | 0(0) | 3(4.92) | 0(0) | 0.422 |
Follow-up days | 608(303,1180) | 555(341,951) | 692(276,1180) | 1451(497,2132) | 0.199 |